Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-jun Fan

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Thoracic Cancer|July 25, 2018
Expert consensus on image-guided radiofrequency ablation of pulmonary tumors: 2018 editionBao-Dong Liu, Xin Ye, Wei-Jun Fan, et al.
Journal for Immunotherapy of Cancer|February 27, 2021
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcomaYi Que, Xiao-Long Zhang, Ze-Xian Liu, et al.
European Radiology Experimental|June 16, 2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.
Hepatology International|October 21, 2023
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Thoracic Cancer|July 25, 2018
Expert consensus on image-guided radiofrequency ablation of pulmonary tumors: 2018 editionBao-Dong Liu, Xin Ye, Wei-Jun Fan, et al.
Journal for Immunotherapy of Cancer|February 27, 2021
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcomaYi Que, Xiao-Long Zhang, Ze-Xian Liu, et al.
European Radiology Experimental|June 16, 2026
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysisRong Ding, Xiao-Yang Xu, Rui-Bao Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.
Hepatology International|October 21, 2023
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendationsMing Zhao, Zhi Guo, Ying-Hua Zou, et al.
Pageof 6